8-K: Ryan Specialty Reports Mixed Q4, Launches $300M Buyback

Ryan Specialty Holdings, Inc. announced its fourth quarter and full year 2025 results, revealing strong revenue growth alongside declining net income, and initiated a three-year restructuring program and a $300 million share repurchase authorization.

Summary

• Total revenue for Q4 2025 increased 13.2% year-over-year to $751.2 million, and for the full year 2025, it grew 21.3% to $3,051.1 million.
• Organic Revenue Growth Rate for Q4 2025 was 6.6%, down from 11.0% in the prior-year period, and for the full year 2025, it was 10.1%, down from 12.8%.
• Net Income for Q4 2025 decreased 26.6% to $31.2 million, and for the full year 2025, it decreased 6.9% to $214.2 million.
• Adjusted EBITDAC for Q4 2025 increased 2.9% to $222.3 million, with a margin of 29.6% (down from 32.6%), and for the full year 2025, it increased 19.2% to $966.7 million, with a margin of 31.7% (down from 32.2%).
• Adjusted Diluted Earnings Per Share for Q4 2025 remained flat at $0.45, and for the full year 2025, it increased 9.5% to $1.96.
• The Board approved a three-year restructuring program, the 'Empower Program,' commencing in Q1 2026, expected to generate approximately $80 million of annual savings by 2029, with cumulative pre-tax charges estimated at $160 million through 2028.
• A share repurchase program authorizing up to $300 million of Class A common stock was approved.
• The regular quarterly dividend was increased by 8.3% to $0.13 per share.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive report. Strong revenue growth and strategic capital allocation (share repurchase, dividend increase) are offset by decelerating organic growth, declining GAAP net income, and significant restructuring costs, indicating a period of strategic adjustment rather than unbridled expansion.

Positives

• Total revenue grew significantly, up 13.2% in Q4 2025 to $751.2 million and 21.3% for the full year 2025 to $3,051.1 million.
• Adjusted EBITDAC increased 2.9% in Q4 2025 to $222.3 million and 19.2% for the full year 2025 to $966.7 million.
• Adjusted Net Income increased 0.5% in Q4 2025 to $124.0 million and 11.1% for the full year 2025 to $548.2 million.
• Adjusted Diluted Earnings per Share increased 9.5% for the full year 2025 to $1.96.
• The company closed 5 high-quality acquisitions in 2025, adding over $125 million in annualized revenue.
• The Board authorized a $300 million share repurchase program, signaling confidence in the business and a commitment to enhanced shareholder returns.
• The regular quarterly dividend was increased by 8.3% to $0.13 per share, payable on March 10, 2026.

Negatives

• Organic Revenue Growth Rate decelerated to 6.6% in Q4 2025 from 11.0% in the prior-year period, and to 10.1% for the full year 2025 from 12.8%.
• Net Income decreased 26.6% in Q4 2025 to $31.2 million and 6.9% for the full year 2025 to $214.2 million.
• Diluted Earnings per Share decreased to $0.06 in Q4 2025 from $0.10, and to $0.47 for the full year 2025 from $0.71.
• Adjusted EBITDAC Margin declined to 29.6% in Q4 2025 from 32.6% and to 31.7% for the full year 2025 from 32.2%.
• The 'Empower Program' restructuring is expected to result in cumulative pre-tax charges of approximately $160 million through 2028, with 95% resulting in future cash expenditures.
• Total operating expenses increased 19.0% in Q4 2025, primarily due to higher compensation and benefits expenses and increased general and administrative expenses.

Risks

• Forward-looking statements are subject to substantial risks and uncertainties that may cause actual results to differ materially from expectations.
• Uncertainty regarding whether the Company will achieve the associated objectives with its Empower Program.
• The possibility that costs and charges associated with restructuring initiatives may exceed current estimates and forecasts.
• Risks related to the Company's ability to realize expected benefits from the Empower Program in the amounts and at the times anticipated.
• Changes in management's assumptions could impact future performance.
• Challenges in achieving anticipated financial results.
• Risks associated with acquisitions, divestitures, joint ventures, and strategic investments.
• Outcomes of legal and regulatory matters.
• Changes in legislation or regulations.

Future Outlook

For the full year 2026, the company is guiding to an Organic Revenue Growth Rate in the high single digits and an Adjusted EBITDAC Margin of flat to moderately down compared to the prior year period. Management anticipates continued industry-leading organic growth for years to come.

Management Comments

• "Overall, 2025 was a strong year for Ryan Specialty, particularly considering the significant headwinds the industry faced." Patrick G. Ryan, Founder and Executive Chairman.
• "For the year, we grew total revenue 21%, supported by organic growth of 10.1% and strong contributions from M&A, which added 10% to our top line. This marked our seventh consecutive year growing total revenue by 20% or more." Patrick G. Ryan, Founder and Executive Chairman.
• "Along with our strong results, we executed our M&A strategy by closing 5 high quality acquisitions, which will add over $125 million in annualized revenue and further distinguish Ryan Specialty as an industry-leading international insurance services firm." Patrick G. Ryan, Founder and Executive Chairman.
• "Reflective of our confidence in the near and long-term outlook of our business, the Board has authorized a $300 million share repurchase program. We believe adding repurchases to our capital allocation toolkit is aligned with our goal of enhanced shareholder returns over the near and long term." Patrick G. Ryan, Founder and Executive Chairman.
• "Ryan Specialty once again led from the front in 2025. We marked our 15th consecutive year of double-digit organic revenue growth, added top-tier talent through hiring and acquisitions, expanded our market share, launched new innovative products and solutions, and produced exceptional results in the face of a rapidly evolving insurance and macroeconomic environment." Timothy W. Turner, Chief Executive Officer.
• "We are off to a strong start in 2026, and believe we will continue to deliver industry-leading organic growth for years to come." Timothy W. Turner, Chief Executive Officer.

Industry Context

StockSavvy.ai notes that Ryan Specialty's performance in 2025 occurred amidst 'significant headwinds the industry faced' and a 'rapidly evolving insurance and macroeconomic environment.' Despite these challenges, the company highlighted continued expansion in the E&S (Excess & Surplus) market and positioned itself as an 'industry-leading international insurance services firm' through strategic M&A and organic growth initiatives. The focus on streamlining operations and accelerating technology strategies through the Empower Program suggests a proactive approach to maintaining competitiveness and efficiency within a dynamic sector.

Comparison to Industry Standards

• The company's claim of '15th consecutive year of double-digit organic revenue growth' (though Q4 2025 organic growth was 6.6%) and 'seventh consecutive year growing total revenue by 20% or more' positions it as a strong performer relative to many peers in the insurance services industry, which often face more volatile growth rates.
• The acquisition of 5 high-quality firms adding over $125 million in annualized revenue demonstrates an aggressive M&A strategy, comparable to other consolidators in the specialty insurance and brokerage space seeking to expand market share and capabilities.
• The initiation of a significant restructuring program, the 'Empower Program,' with an estimated $160 million in charges for $80 million in annual savings by 2029, indicates a commitment to long-term efficiency and scale optimization, a common strategic move among mature industry players looking to enhance profitability in competitive markets.

Corporate Governance

Stakeholder Impact

• Shareholders: Benefit from the increased quarterly dividend and the potential for enhanced share value through the $300 million share repurchase program.
• Employees: The 'Empower Program' is designed to streamline operations, which may involve changes to roles or headcount, particularly in brokerage, binding, and underwriting operations, though not explicitly stated as layoffs.
• Customers: Expected to benefit from enhanced efficiencies and accelerated data and technology strategies resulting from the 'Empower Program', potentially leading to improved service delivery.
• Creditors: The company's outstanding debt principal of $3.4 billion and the significant cash expenditures associated with the restructuring program will be relevant for assessing credit risk, though the program aims for long-term efficiency.

Next Steps

• The 'Empower Program' restructuring will commence in the first quarter of 2026.
• The regular quarterly dividend of $0.13 per share will be payable on March 10, 2026.
• The company will continue to execute its share repurchase program, with timing and volume dependent on market conditions.
• Management expects to continue delivering industry-leading organic growth for years to come.

Key Dates

Recommendation

Ryan Specialty's Q4 and full-year 2025 results present a mixed picture. While total revenue growth remains robust, driven by M&A, the deceleration in organic revenue growth and declines in GAAP net income and margins are concerning. The 'Empower Program' is a necessary strategic move to enhance efficiency, but it comes with significant upfront costs. The share repurchase authorization and increased dividend are positive for shareholder returns. However, the cautious 2026 outlook (high single-digit organic growth, flat to moderately down Adjusted EBITDAC Margin) suggests ongoing headwinds. Investors should hold to monitor the execution of the Empower Program and its impact on profitability and organic growth, as well as the broader industry environment.

Keywords

Specialty Insurance, Wholesale Brokerage, Underwriting Management, Binding Authority, Restructuring Program, Share Repurchase, Dividend, Financial Results, Organic Growth, Adjusted EBITDAC, SEC Filing